Steven J. Frank, MD is Professor, Deputy Division Head, and Director of Advanced Technologies, Department of Radiation Oncology, Division of Radiation Oncology; Medical Director, Department of Proton Therapy Center at The University of Texas MD Anderson Cancer Center. He is the author of Proton Therapy.
Dr. Frank received his MD from Emory University School of Medicine and performed a fellowship in Prostate Brachytherapy at Seattle Prostate Institute. Prior to his medical career, he was a Nuclear Engineer with United States Naval Nuclear Propulsion Program, Washington, D.C.
In addition to his positions noted above at the University of Texas MD Anderson Cancer Center, Dr. Frank is the leader of both the Proton Therapy Program for head and neck cancer and the Prostate Brachytherapy Program. Dr. Frank is amongst the first, if not the first, to use Intensity-Modulated Proton Therapy (IMPT) to treat head and neck tumors.
Dr. Frank’s expertise in MRI radiotherapy has led to the development and FDA approval of a novel positive-contrast implantable marker for use in MRI-guided prostate brachytherapy. As founder of the company, C4 Imaging, Dr. Frank has developed the MRI marker technology at MD Anderson, currently holds 31 national and international patents and has continued MRI-Assisted Radiosurgery (MARS) at MD Anderson for the treatment of prostate cancer. Dr. Frank’s expertise in prostate brachytherapy is reflected by his service as past President and Chairman of the Board of the American Brachytherapy Society. Dr. Frank’s expertise in head and neck cancer has been acknowledged by his chairing the American Board of Radiology’s Oral Examinations Program for head and neck cancer.
Dr. Frank is also Adjunct Associate Professor, Department of Radiation Oncology, The University of Texas Graduate School of Biomedical Sciences at Houston; Adjunct Associate Professor, Department of Radiation Oncology, Division of Diagnostic Imaging, Baylor College of Medicine, Houston; and Adjunct Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, University Medical Center Utrecht, Netherlands.